The Japanese CAR-T therapy market grows 16.3% CAGR amid rising cancer prevalence, biotech innovation, and precision oncology strategies.
CAR-T cell treatments in Japan are revolutionizing cancer care, with the market forecasted to reach $1.35B by 2033 through innovative therapies.